CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 3,100 shares at an average $8.99 ($27,860)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy See Remarks bought 10,000 shares at $9.88 ($98,778)
- 4 Shares withheld for taxes President/CEO gave up 27,166 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,882 shares at $8.50 ($49,997)
- 4 Open-market buy Director bought 11,764 shares at $8.50 ($99,994)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 17,647 shares at $8.50 ($150,000)
Page 4 of 14 · 272 filings